Pursuant to Regulation 47 read with Regulation 33, SMS Pharmaceuticals has enclosed copies of the newspaper advertisements published in The Financial Express (English), and in Andhra Prabha (Telugu), on 09th November, 2023 regarding the unaudited Standalone & Consolidated Financial Results for the second quarter and half year ended 30th September, 2023. This information is also being made available on the website of the Company www.smspharma.com.
The above information is a part of company’s filings submitted to BSE.